These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 3937346

  • 1. [Phospholipase A2 inhibitors in hemorrhagic-necrotizing pancreatitis. Animal experiment evaluation of a new treatment concept].
    Kahle M, Klein U, König W, Martin U, Alles JU.
    Z Gastroenterol; 1985 Dec; 23(12):687-93. PubMed ID: 3937346
    [Abstract] [Full Text] [Related]

  • 2. Lysolecithin concentration in pancreatic tissue during therapy with phospholipase A2-inhibitors in acute necrotizing pancreatitis.
    Kahle M, König H, Filler RD.
    Klin Wochenschr; 1989 Feb 01; 67(3):177-9. PubMed ID: 2494378
    [Abstract] [Full Text] [Related]

  • 3. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis.
    Freise J, Schmidt FW, Magerstedt P, Schmid K.
    Clin Biochem; 1985 Aug 01; 18(4):224-9. PubMed ID: 2412725
    [Abstract] [Full Text] [Related]

  • 4. [Therapy of acute pancreatitis with a synthetic protease and phospholipase A2 inhibitor gabexate mesilate].
    Freise J.
    Fortschr Med; 1983 Aug 25; 101(31-32):1432-6. PubMed ID: 6194089
    [Abstract] [Full Text] [Related]

  • 5. Effects of the serine protease inhibitor gabexate mesilate on purified pancreatic phospholipase A2.
    Hesse B, Lankisch PG, Kunze H.
    Pharmacol Res Commun; 1984 Jul 25; 16(7):637-45. PubMed ID: 6433363
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of porcine pancreas phospholipase A2 activation by gabexate mesilate.
    Schädlich HR, Büchler M, Beger HG.
    Klin Wochenschr; 1989 Feb 01; 67(3):160-2. PubMed ID: 2494376
    [Abstract] [Full Text] [Related]

  • 7. A randomized double-blind study using CaNa2EDTA, a phospholipase A2 inhibitor, in the management of human acute pancreatitis.
    Tykkä HT, Vaittinen EJ, Mahlberg KL, Railo JE, Pantzar PJ, Sarna S, Tallberg T.
    Scand J Gastroenterol; 1985 Jan 01; 20(1):5-12. PubMed ID: 3922048
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthetic antiproteases in acute pancreatitis: an experimental study.
    Dobosz M, Sledziński Z, Babicki A, Juszkiewicz P, Basiński A, Wajda Z.
    Mt Sinai J Med; 1992 Jan 01; 59(1):43-6. PubMed ID: 1734237
    [Abstract] [Full Text] [Related]

  • 10. Phospholipase A2 inhibitors and their possible clinical use in the treatment of acute pancreatitis.
    Tykkä H, Mahlberg K, Pantzar P, Tallberg T.
    Scand J Gastroenterol; 1980 Jan 01; 15(5):519-28. PubMed ID: 6777862
    [Abstract] [Full Text] [Related]

  • 11. In vitro inhibition of phospholipase A2 by gabexate mesilate, camostate, and aprotinine.
    Freise J, Wittenberg H, Magerstedt P.
    Klin Wochenschr; 1989 Feb 01; 67(3):149-52. PubMed ID: 2467043
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinine.
    Freise J, Magerstedt P, Schmid K.
    Enzyme; 1983 Feb 01; 30(3):209-12. PubMed ID: 6194983
    [Abstract] [Full Text] [Related]

  • 13. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
    Freise J, Melzer P, Schmidt FW, Horbach L.
    Z Gastroenterol; 1986 Apr 01; 24(4):200-11. PubMed ID: 3087076
    [Abstract] [Full Text] [Related]

  • 14. Chlorpromazine treatment of experimental acute fulminant pancreatitis in pigs.
    Schröder T, Lempinen M, Nordling S, Kinnunen PK.
    Eur Surg Res; 1981 Apr 01; 13(2):143-51. PubMed ID: 7297579
    [Abstract] [Full Text] [Related]

  • 15. Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis.
    Dobosz M, Sledzinski Z, Juszkiewicz P, Babicki A, Stanek A, Wajda Z, Basinski A.
    Hepatogastroenterology; 1991 Apr 01; 38(2):139-42. PubMed ID: 1855771
    [Abstract] [Full Text] [Related]

  • 16. Effect on hemodynamics of therapeutic infusion of gabexate mesilate (FOY) in experimental acute pancreatitis.
    Dobosz M, Sledziński Z, Basiński A, Stanek A, Babicki A, Wajda Z.
    Res Exp Med (Berl); 1989 Apr 01; 189(2):77-84. PubMed ID: 2499022
    [Abstract] [Full Text] [Related]

  • 17. [The protease inhibitor gabexate mesilate in experimentally-induced acute pancreatitis with early gram-negative infection in the Göttingen minipig: therapeutic efficacy and effects on blood coagulation and fibrinolysis].
    Heitz J, Semsch B, Emde C, Jansen U, Schäfer JH.
    Z Gastroenterol; 1990 Apr 01; 28(4):192-7. PubMed ID: 2119091
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effect of gabexate mesilate on pancreatic phospholipase A2-mediated hydrolysis of ghost membranes.
    Nishijima J, Okamoto M, Nakaguchi K, Ogawa M, Yamano T, Mori T.
    Gen Pharmacol; 1985 Apr 01; 16(3):177-82. PubMed ID: 3926598
    [Abstract] [Full Text] [Related]

  • 19. Influence of aprotinin and gabexate mesilate on arachidonic acid release by the Ca-ionophore A 23187 in the lung.
    Seeger W, Wolf H, Graubert E, Moser U, Neuhof H, Roka L.
    Adv Exp Med Biol; 1983 Apr 01; 156():553-67. PubMed ID: 6190378
    [Abstract] [Full Text] [Related]

  • 20. Effect of a new inhibitor of type II phospholipase A2 on experimental acute pancreatitis in rats.
    Yoshikawa T, Naruse S, Kitagawa M, Ishiguro H, Nakae Y, Ono T, Hayakawa T.
    Pancreas; 1999 Aug 01; 19(2):193-8. PubMed ID: 10438167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.